Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

Ansarin, 2020
 
IRCT202003117046797N
RCTbromhexinestandard of careCOVID 19 hospitalizedhigh
39/39 suggested
  • suggested 91 % decrease in ventilation but with a low degree of certainty due to high risk of bias

COVID-19 mild to moderate meta-analysis

Li T, 2020
 
NCT04273763
RCTbromhexinestandard of careCOVID-19 mild to moderatesome concern
12/6 suggested
  • suggested 9.0-fold increase in hospital discharge with a moderate degree of certainty due to some concern in risk of bias

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).